PET/CT and Patient Outcomes, Part II, An Issue of PET Clinics , livre ebook

Clinics Review Articles PET CLINICS
PET/CT and Patient Outcomes, Part II

Rathan M. Subramaniam, MD, PhD, MPH
Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, USA
ISSN  1556-8598 Volume 10 • Number 3 • July 2015
Elsevier
Table of Contents
Cover image
Title page
Copyright
Contributors
Consulting Editor
Editor
Authors
Forthcoming Issues
Forthcoming Issues
Recent Issues
CME Accreditation Page
Target Audience
Learning Objectives
Accreditation
Disclosure of Conflicts of Interest
Unapproved/Off-Label Use Disclosure
To Enroll
Method of Participation
CME Inquiries/Special Needs
PET/CT: Defining Value to Patients and Health Systems
Role of 2-Fluoro-2-Deoxyglucose PET/Computed Tomography in Carcinoma of Unknown Primary
Key points
Introduction
Why PET/computed tomography?
Protocol for 2-fluoro-2-deoxyglucose PET/computed tomography
Interpretation of images
Performance of 2-fluoro-2-deoxyglucose PET/computed tomography in carcinoma of unknown primary: a critical appraisal
The clinical impact: probable future developments in management of carcinoma of unknown primary
The shortcomings
Summary and further directions
PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers
Key points
Introduction
Gastric adenocarcinoma
Imaging of the primary tumor
Initial diagnosis
Differential diagnosis
Staging
Prognosis
Therapy
Response to therapy
Detection of recurrence
Other radiotracers
Gastric lymphoma
Gastrointestinal stromal tumor
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas
Key points
Introduction
The role of PET/computed tomography imaging in diagnosis, management, and outcome
Fludeoxyglucose F 18 PET/computed tomography in staging and therapy planning of biliary tract cancers
Fludeoxyglucose F 18 PET/computed tomography in staging and therapy planning of hepatocellular carcinoma
Summary
Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer
Key points
Introduction
Search
Primary staging
Liver metastases
Suspected recurrence of disease
Detecting recurrence with fluorodeoxyglucose-PET/computed tomography in patients with increased carcinoembryonic antigen levels
Detecting recurrence of colorectal cancer in patients with normal levels of carcinoembryonic antigen
Assessment of treatment response
Rectal cancer
Summary
PET/Computed Tomography in Renal, Bladder, and Testicular Cancer
Key points
Introduction
Use of PET in renal cell carcinoma
Use of PET in bladder cancer
Use of PET in testicular cancer
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas
Key points
Introduction
Osteosarcoma
Ewing sarcoma
Chondrosarcoma
Rhabdomyosarcoma
Liposarcoma
Malignant fibrous histiocytoma
Gastrointestinal stromal tumors
Summary
Fludeoxyglucose F 18 PET–Computed Tomography
Key points
Introduction
Endometrial cancer
Ovarian cancer
Cervical cancer
PET/Computed Tomography in Neuroendocrine Tumor
Key points
Introduction
18F-dopa/18F-dopamine PET/computed tomography
Gallium 68 somatostatin derivatives PET/computed tomography
18F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors
Key points
Introduction
MR imaging
18F-flourodeoxy-glucose PET/computed tomography
Gliomas
Patient management and survival outcome
Imaging evaluation: tumor grade
Imaging evaluation: recurrence versus pseudoprogression and tumor necrosis
Novel radiotracers
Primary central nervous system lymphoma
Summary
18-Fluoro-deoxyglucose–PET/Computed Tomography in Infection and Aseptic Inflammatory Disorders
Key points
Introduction
Fever of unknown origin/pyrexia of unknown origin
Spinal infection
Granulomatous disorders
Peripheral bone osteomyelitis including diabetic foot
Infection related to prosthesis: joint prosthesis (hip and knee), vascular prosthesis and graft infection
Other soft tissue infections and inflammation including vasculitis
Cardiac PET/Computed Tomography Applications and Cardiovascular Outcome
Key points
Introduction
Perfusion and flow in coronary artery disease detection
Enhanced identification of coronary artery disease burden
Identification of diffuse ischemia
Identification of subclinical coronary artery disease and prognostic implications
Monitoring reductions in cardiovascular risk with PET
Identification of hibernating-stunning myocardium in ischemic cardiomyopathy
PET/computed tomography in cardiac sarcoid involvement
Summary
Copyright
ELSEVIER
1600 John F. Kennedy Boulevard • Suite 1800 • Philadelphia, Pennsylvania, 19103-2899
http://www.pet.theclinics.com
Volume 10, Number 3
July 2015 ISSN 1556-8598, ISBN-13: 978-0-323-39111-5
Editor: John Vassallo (j.vassallo@elsevier.com)
Developmental Editor: Meredith Clinton
© 2015 Elsevier Inc. All rights reserved.
This periodical and the individual contributions contained in it are protected under copyright by Elsevier, and the following terms and conditions apply to their use:
Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the Publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use. For information on how to seek permission visit www.elsevier.com/permissions or call: (+44) 1865 843830 (UK)/(+1) 215 239 3804 (USA).
Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution. Permission of the Publisher is required for all other derivative works, including compilations and translations (please consult www.elsevier.com/permissions ).
Electronic Storage or Usage
Permission of the Publisher is required to store or use electronically any material contained in this periodical, including any article or part of an article (please consult www.elsevier.com/permissions ). Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Publisher.
Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
PET Clinics (ISSN 1556-8598) is published quarterly by Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Months of issue are January, April, July, and October. Periodicals postage paid at New York, NY, and additional mailing offices. Subscription prices per year are $225.00 (US individuals), $327.00 (US institutions), $115.00 (US students), $255.00 (Canadian individuals), $369.00 (Canadian institutions), $140.00 (Canadian students), $275.00 (foreign individuals), $369.00 (foreign institutions), and $140.00 (foreign students). To receive student and resident rate, orders must be accompanied by name of affiliated institution, date of term, and the signature of program/residency coordinator on institution letterhead. Orders will be billed at individual rate until proof of status is received. Foreign air speed delivery is included in all Clinics subscription prices. All prices are subject to change without notice. POSTMASTER: Send address changes to PET Clinics, Elsevier Health Sciences Division, Subscription Customer Service, 3251 Riverport Lane, Maryland Heights, MO 63043. Customer Service: 1-800-654-2452 (U.S. and Canada); 314-447-8871 (outside U.S. and Canada). Fax: 314-447-8029. E-mail: journalscustomerservice-usa@elsevier.com (for print support); journalsonlinesupport-usa@elsevier.com (for online support).
Reprints . For copies of 100 or more of articles in this publication, please contact the Commercial Reprints Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710. Tel.: 212-633-3874; Fax: 212-633-3820; E-mail: reprints@elsevier.com .
Printed in the United States of America.
PET Clinics is covered in MEDLINE/PubMed (Index Medicus).
Contributors

Consulting Editor